Skip to content

Chemed CHE Deferred Compensation Liability, Classified, Noncurrent

Deferred Compensation Liability, Classified, Noncurrent at other companies

GHC
Graham HoldingsGHC

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's deferred compensation liability, classified, noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's deferred compensation liability, classified, noncurrent?
Chemed (CHE) reported deferred compensation liability, classified, noncurrent of $142.66M in Q1 2026.
How has Chemed's deferred compensation liability, classified, noncurrent changed year-over-year?
Chemed's deferred compensation liability, classified, noncurrent increased by 12.1% year-over-year, from $127.29M to $142.66M.
What is the long-term trend for Chemed's deferred compensation liability, classified, noncurrent?
Over 5 years (2020 to 2025), Chemed's deferred compensation liability, classified, noncurrent has grown at a 9.0% compound annual growth rate (CAGR), from $88.46M to $136.14M.